Development and Validation of Spectrophotometric and Colorimetric Method for the Determination of Ritonavir in its Bulk and Pharmaceutical Dosage Form
DOI:
https://doi.org/10.37591/tdd.v4i3.74Abstract
A straightforward, exact, precise and sensitive UV spectrophotometric assay technique and a basic and sensitive colorimetric assay method have been created and validated for the quantitative estimation of Ritonavir from bulk drug and tablet formulations. UV spectrophotometric strategy which includes the assurance of Ritonavir in bulk medication and pharmaceutical dosage forms and has an assimilation greatest at 240 nm in methanol. The Beer's law was obeyed over the concentration range of 10– 50µg/ml. The relationship coefficient was observed to be 0.9996 and it has demonstrated great linearity, reproducibility, accuracy in this fixation go. The % recuperation esteems were observed to be inside 98.76% - 99.73% demonstrated that the strategy was exact. The LOD and LOQ were observed to be 1.6µg/ml and 4.9µg/ml separately. The % RSD esteems were under 2. Colorimetric technique which includes the assurance of Ritonavir in mass medication and pharmaceutical dose frames. This method is based on the reaction of Ritonavir with 1 ml, 0.5% ferric chloride and 1ml, 0.2% potassium ferric cyanide to produce a bluish green colour, characteristic light absorption at 452 nm. The Beer’s law was obeyed over the concentration range of 20–100 µg/ml. The correlation coefficient was found to be 0.9997 and it has showed good linearity, reproducibility, precision in this concentration range. The % recovery values were found to be within 99.67–100.45% showed that the method was accurate. The LOD and LOQ were found to be 2.6 µg/ml and 7.9 µg/ml respectively. The % RSD values were less than 2.
Keywords: Ritonavir, Potassium ferri cyanide, Ferric chloride, spectroscopy, method development, validation
Cite this Article
V. Devi Singh, G. Ashok, Taher Patel et al. Development and Validation of Spectrophotometric and Colorimetric Method for the Determination of Ritonavir in Its Bulk and Pharmaceutical Dosage Form. Trends in Drug Delivery. 2017; 4(3): 32–41p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
